CD274 and non-small cell lung carcinoma: While smoking is generally associated with a poor prognosis, the high PD-L1 expression and TMB commonly observed in smokers would suggest that the smoking history may be relevant to response to immune checkpoint immunotherapy (ICI), particularly for non-small cell lung cancer (NSCLC) (14).